CIK 0001157601 · Large accelerated filer
MADRIGAL PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- MDGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (267) 824-2827
- Business address
- 1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
- Former names
- MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
- Open-market buys, last 90 days
- $35,023,032
- in 1 filing
- Open-market sales, last 90 days
- $7,011,938
- in 3 filings, $6.7M under 10b5-1 plans
Net +$28,011,094. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-07-16 | Taub Rebecca Director | Sale 10b5-1 | −1,897 | $351.37 | $667K | 479,591 |
| 2025-07-16 | Taub Rebecca Director | Sale 10b5-1 | −2,357 | $352.64 | $831K | 477,234 |
| 2025-07-16 | Taub Rebecca Director | Sale 10b5-1 | −2,569 | $353.82 | $909K | 474,665 |
| 2025-07-16 | Taub Rebecca Director | Sale 10b5-1 | −5,800 | $354.61 | $2.1M | 468,865 |
| 2025-07-16 | Taub Rebecca Director | Sale 10b5-1 | −6,441 | $355.61 | $2.3M | 462,424 |
| 2025-07-16 | Taub Rebecca Director | Sale 10b5-1 | −1,380 | $356.52 | $492K | 461,044 |
| 2025-07-16 | Taub Rebecca Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −26,444 | 50,120 | ||
| 2025-06-20 | BATE KENNETH Director | Grant or award | +715 | 2,627 | ||
| 2025-06-20 | BATE KENNETH Director | Grant or award · Stock Option (Right to Buy) | +1,290 | 1,290 | ||
| 2025-06-20 | Levy Richard S Director | Grant or award | +715 | 21,197 | ||
| 2025-06-20 | Levy Richard S Director | Grant or award · Stock Option (Right to Buy) | +1,290 | 1,290 | ||
| 2025-06-20 | FOUSE JACQUALYN A Director | Grant or award | +203 | 1,097 | ||
| 2025-06-20 | FOUSE JACQUALYN A Director | Grant or award · Stock Option (Right to Buy) | +366 | 366 | ||
| 2025-06-20 | Daly James M Director | Grant or award | +715 | 2,627 | ||
| 2025-06-20 | Daly James M Director | Grant or award · Stock Option (Right to Buy) | +1,290 | 1,290 | ||
| 2025-06-20 | FRIEDMAN PAUL A Director | Grant or award | +715 | 187,164 | ||
| 2025-06-20 | FRIEDMAN PAUL A Director | Grant or award · Stock Option (Right to Buy) | +1,290 | 1,290 | ||
| 2025-06-20 | BAKER BROS. ADVISORS LP Director | Grant or award | +1,430 | 188,837 | ||
| 2025-06-20 | BAKER BROS. ADVISORS LP Director | Grant or award | +1,430 | 1,796,261 | ||
| 2025-06-20 | BAKER BROS. ADVISORS LP Director | Grant or award · Non- Qualified Stock Options (right to buy) | +2,580 | 2,580 |
Page 22 of 82 · 1,629 trades